Jorge Flores

9.3k total citations · 1 hit paper
112 papers, 7.3k citations indexed

About

Jorge Flores is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Jorge Flores has authored 112 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Infectious Diseases, 40 papers in Epidemiology and 38 papers in Animal Science and Zoology. Recurrent topics in Jorge Flores's work include Viral gastroenteritis research and epidemiology (82 papers), Animal Virus Infections Studies (38 papers) and Viral Infections and Immunology Research (29 papers). Jorge Flores is often cited by papers focused on Viral gastroenteritis research and epidemiology (82 papers), Animal Virus Infections Studies (38 papers) and Viral Infections and Immunology Research (29 papers). Jorge Flores collaborates with scholars based in United States, Venezuela and Vietnam. Jorge Flores's co-authors include Albert Z. Kapikian, Yasutaka Hoshino, Harry B. Greenberg, Anthony R. Kalica, Richard G. Wyatt, M Gorziglia, Roger I. Glass, Bimal Kumar Das, Patricia Woods and M. K. Bhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Gastroenterology.

In The Last Decade

Jorge Flores

110 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of group A rotavirus gene 4 types by polymerase chain reaction

1992 1.2k citations M Gorziglia, Jorge Flores et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Flores United States	48	6.7k	3.2k	2.8k	1.6k	1.3k	112	7.3k
H. F. Clark United States	40	4.7k 0.7×	2.6k 0.8×	2.3k 0.8×	982 0.6×	1.2k 1.0×	139	6.0k
Ulrich Desselberger United Kingdom	53	7.8k 1.2×	4.0k 1.2×	3.4k 1.2×	1.2k 0.7×	1.8k 1.4×	208	10.5k
Krisztián Bànyai Hungary	48	8.9k 1.3×	4.6k 1.5×	5.1k 1.8×	1.3k 0.8×	2.0k 1.6×	340	9.9k
Baoming Jiang United States	51	6.6k 1.0×	3.5k 1.1×	2.7k 0.9×	703 0.4×	2.2k 1.8×	172	7.5k
Naokazu Takeda Japan	54	9.2k 1.4×	4.2k 1.3×	3.0k 1.1×	1.4k 0.8×	3.6k 2.8×	240	11.1k
R. M. Chanock United States	44	4.3k 0.6×	1.3k 0.4×	1.6k 0.6×	1.4k 0.8×	446 0.4×	102	5.9k
David O. Matson United States	43	4.8k 0.7×	2.2k 0.7×	2.3k 0.8×	897 0.6×	1.1k 0.9×	129	5.5k
Jelle Matthijnssens Belgium	49	9.2k 1.4×	5.7k 1.8×	5.3k 1.9×	744 0.5×	2.3k 1.9×	207	10.0k
Vito Martella Italy	65	13.9k 2.1×	4.9k 1.5×	9.7k 3.5×	6.5k 4.0×	2.1k 1.7×	459	17.1k
Canio Buonavoglia Italy	63	9.9k 1.5×	2.0k 0.6×	8.2k 2.9×	7.0k 4.4×	585 0.5×	374	13.8k

Countries citing papers authored by Jorge Flores

Since Specialization

Citations

This map shows the geographic impact of Jorge Flores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Flores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Flores more than expected).

Fields of papers citing papers by Jorge Flores

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Flores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Flores. The network helps show where Jorge Flores may publish in the future.

Co-authorship network of co-authors of Jorge Flores

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Flores. A scholar is included among the top collaborators of Jorge Flores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Flores. Jorge Flores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keech, Cheryl, Porter Anderson, Jorge Flores, et al.. (2020). A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults. The Pediatric Infectious Disease Journal. 39(4). 345–351. 19 indexed citations

Fix, Alan, Carl D. Kirkwood, A. Duncan Steele, & Jorge Flores. (2020). Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19–20 June 2019, Geneva). Vaccine. 38(52). 8247–8254. 8 indexed citations

Hausdorff, William P. & Jorge Flores. (2020). Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19. International Journal of Infectious Diseases. 103. 37–41. 8 indexed citations

Clarke, Ed, Rajeev Dhere, Beate Kampmann, et al.. (2019). Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial. Vaccine. 38(2). 399–410. 18 indexed citations

Victor, John C., et al.. (2018). Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam. Vaccine. 36(46). 6918–6925. 2 indexed citations

Rudenko, Larisa, Irina Kiseleva, Marina Stukova, et al.. (2015). Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study. Vaccine. 33(39). 5110–5117. 26 indexed citations

Malaspina, Angela, Charles R. Rinaldo, Rafick‐Pierre Sékaly, Jorge Flores, & Patricia D’Souza. (2011). “In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates”, NIAID Workshop Report, Bethesda, August 4, 2010. Vaccine. 29(29-30). 4647–4653. 2 indexed citations

Shattock, Robin J., et al.. (2008). Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity. PLoS Medicine. 5(4). e81–e81. 47 indexed citations

Lau, Chuen‐Yen, et al.. (2008). Broadening inclusion of vulnerable populations in HIV vaccine trials. Expert Review of Vaccines. 7(2). 259–268. 9 indexed citations

10.

Montefiori, David C., et al.. (2007). Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions. PLoS Medicine. 4(12). e348–e348. 65 indexed citations

11.

Wright, Peter F., Jiří Městecký, M. Juliana McElrath, et al.. (2004). Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV‐1 Genes or the Gene for Rabies Virus G Protein. The Journal of Infectious Diseases. 189(7). 1221–1231. 45 indexed citations

12.

Cao, H., Pontiano Kaleebu, David L. Hom, et al.. (2003). Immunogenicity of a Recombinant Human Immunodeficiency Virus (HIV)–Canarypox Vaccine in HIV‐Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine Study. The Journal of Infectious Diseases. 187(6). 887–895. 49 indexed citations

13.

Ferrari, Guido, Donna D. Kostyu, Josephine H. Cox, et al.. (2000). Identification of Highly Conserved and Broadly Cross-Reactive HIV Type 1 Cytotoxic T Lymphocyte Epitopes as Candidate Immunogens for Inclusion in Mycobacterium bovis BCG-Vectored HIV Vaccines. AIDS Research and Human Retroviruses. 16(14). 1433–1443. 46 indexed citations

14.

Gerna, Giuseppe, A. Duncan Steele, Yasutaka Hoshino, et al.. (1994). A comparison of the VP7 gene sequences of human and bovine rotaviruses. Journal of General Virology. 75(7). 1781–1784. 20 indexed citations

15.

Gerna, Giuseppe, Yasutaka Hoshino, A. Duncan Steele, et al.. (1994). Identification of a New VP4 Serotype of Human Rotaviruses. Virology. 200(1). 66–71. 52 indexed citations

16.

Kapikian, A. Z., Jorge Flores, Timo Vesikari, et al.. (1991). Recent Advances in Development of a Rotavirus Vaccine for Prevention of Severe Diarrheal Illness of Infants and Young Children. Advances in experimental medicine and biology. 310. 255–264. 13 indexed citations

17.

Vesikari, Timo, et al.. (1991). Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. PubMed. 10(12). 912–917. 52 indexed citations

18.

Flores, Jorge, A Z Kapikian, Irene Pérez‐Schael, et al.. (1990). Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine. The Lancet. 336(8711). 330–334. 49 indexed citations

19.

Kapikian, Albert Z., Jorge Flores, Yasutaka Hoshino, et al.. (1989). Prospects for Development of a Rotavirus Vaccine Against Rotavirus Diarrhea in Infants and Young Children. Clinical Infectious Diseases. 11(Supplement_3). S539–S546. 26 indexed citations

20.

Krause, Peter J., Jeffrey S. Hyams, Peter J. Middleton, Victor Herson, & Jorge Flores. (1983). Unreliability of Rotazyme ELISA test in neonates. The Journal of Pediatrics. 103(2). 259–262. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact